Abstracts

Citation

Mona Rigaud, M.D., William Borkowsky, M.D., Adriana Weinberg, M.D., Philip LaRussa, M.D., Petronella Muresan, M.S., Terence Fenton, Ed.D., Shirley Jankelevich, M.D., Jennifer S. Read, M.D., M.P.H., M.S., DTM&H, Bonnie Zimmer, B.S. Lymphoproliferative (LP) and Serological (SR) Responses to recall and neoantigens in severely immunocompromised HIV-infected children initiating HAART--48 weeks follow-up. Presented at: 11th Conference on Retroviruses and Opportunistic Infections.

Citation

William Borkowsky, M.D., Diane W. Wara, M.D., James McNamara, M.D., Minhee Kang, M.S., Ph.D., Terence Fenton, Ed.D., Elizabeth (Betsy) J. McFarland, M.D., Coleen K. Cunningham, M.D., Lynne M. Mofenson, M.D., F.A.A.P., Anne-Marie Duliege, M.D., M.S., Donald P. Francis, M.D., D.Sc. Lymphoproliferative Responses (LP) to REC HIV-1 Envelope Antigens in Neonates & Infants Receiving GP120 Vaccines.

Citation

Lymphoproliferative Responses (LP) to Recombinant HIV-1 Envelope Antigens in Neonates & Infants Receiving gp120 Vaccines.

Citation

Magnitude and persistence of humoral, mucosal and cell-mediated immunity (CMI) after administering quadrivalent human papillomavirus vaccine (QHPV) to HIV+ children and cross-reactivity with nonvaccine serotypes.

Citation

J Rosebush, B Best, E Chadwick, J Moye, E Smith, K Bulter, S Bradford, K Whitson, SR Mathiba, S Hanley, M Aziz, K Hayward, M Mirochnick, P Samson for the IMPAACT 2007 study team. Maraviroc safety & pharmacokinetics in HIV-exposed neonates. Presented at: CROI 2020.

Citation

A Weinberg, Y Huo, D Kacanek, K Patel, H Watts, D Wara, J Klawitter, U Christians for the P1025 team. Markers of preterm delivery in HIV+ women; Role of protease inhibitors and vitamin D. Presented at: CROI 2018; 2018 Mar 07.

Citation

Violet Korutaro, Lauren Ziemba, Sean Brummel, Anne Coletti, Patrick Jean-Philippe, Nahida Chakhtoura, Benjamin Johnson, Lynda Stranix Chibanda, Lee Fairlie, Roger Shapiro, Deo Wabwire, Patricia Nahirya Ntege, Lameck Chinula, Shahin Lockman, IMPAACT 2010/VESTED Team. Maternal and Infant Predictors of Mortality in Liveborn Infants in the IMPAACT 2010 (VESTED) Trial. Presented at: CROI 2026; 2026 Feb 23.

Citation

Kristina Adachi, Jiahong Xu, Bonnie Ank, D. Heather Watts, Esau Joao, JH Pilotto, Yvonne Bryson, Valdilea Veloso, Lynne Mofenson, Karin Nielsen-Saines for the HPTN 040 team. Maternal CMV Urinary Shedding and Congenital CMV Infection in HIV-infected Mothers. Presented at: CROI 2016; 2016 Feb 23.

Citation

P. S. Eastman. Maternal Genotypic Zidovudine (ZDV) Resistance and Failure of ZDV Therapy to Prevent Mother-Child HIV-1 Transmission.

Citation

D Bhattacharya, R Guo, C Tseng, L Emel, R Sun, S Chiu, L Stranix-Chibanda, T Chipato, NZ Mohtashemi, K Kintu, KP Manji, D Moodley, C Thio, Y Maldonado, J Currier. Maternal HBV viremia is associated with adverse infant outcomes in HIV/HBV women. Presented at: CROI 2019; 2019 Mar 05.